Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors
Authors:
- 9 January 2023
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (2) , 249-259
Abstract
With the advancements in therapeutics for non-Hodgkin lymphoma (NHL), the long-term survival of patients with NHL has markedly increased. Second primary malignancies (SPMs) have become an increasingly relevant long-term concern for NHL survivors. The etiology of SPMs is multifactorial and involves multiple steps. Germline alterations, immune dysregulation, and clonal hematopoiesis contribute to the accumulation of intrinsic adverse factors, and external factors such as lifestyle; exposure to infectious factors; and late effects of radiotherapy, chemotherapy, high-dose therapy, and autologous hematopoietic stem cell transplantation further increase SPM risk. Therapy-related myeloid neoplasms (t-MNs) are a devastating complication of cytotoxic chemotherapeutic agents. However, as targeted therapies begin to replace cytotoxic chemotherapy, the incidence of t-MNs is likely to decline, particularly for indolent B-cell NHL.Keywords
This publication has 82 references indexed in Scilit:
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based studyBritish Journal of Cancer, 2011
- Cigarette Smoking, Passive Smoking, and Non-Hodgkin Lymphoma Risk: Evidence From the California Teachers StudyAmerican Journal of Epidemiology, 2011
- Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphomaCancer Letters, 2011
- Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphomaHaematologica, 2011
- Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysisAnnals of Oncology, 2011
- Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma SubtypeJournal of Clinical Oncology, 2010
- Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort studyThe Lancet Oncology, 2010
- Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since DiagnosisJournal of Clinical Oncology, 2008
- Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort StudyJournal of Clinical Oncology, 2006